Zobrazeno 1 - 10
of 115
pro vyhledávání: '"Ke Fei Dou"'
Autor:
Sha Li, Hui‐Hui Liu, Yan Zhang, Meng Zhang, Hui‐Wen Zhang, Cheng‐Gang Zhu, Na‐Qiong Wu, Rui‐Xia Xu, Qian Dong, Jie Qian, Ke‐Fei Dou, Yuan‐Lin Guo, Jian‐Jun Li
Publikováno v:
MedComm, Vol 5, Iss 11, Pp n/a-n/a (2024)
Abstract Lipoprotein(a) [Lp(a)] is an emerging predictor for atherosclerotic cardiovascular disease (ASCVD) but the association from a perspective on current risk stratification was unknown. A cohort of 9944 Chinese patients with ASCVD was recruited
Externí odkaz:
https://doaj.org/article/02bd5b4b9dee4206a6ddf6fb1ddf175e
Autor:
Sha Li, Hui-Hui Liu, Yan Zhang, Meng Zhang, Hui-Wen Zhang, Cheng-Gang Zhu, Yuan-Lin Guo, Na-Qiong Wu, Rui-Xia Xu, Qian Dong, Ke-Fei Dou, Jie Qian, Jian-Jun Li
Publikováno v:
Journal of Obesity & Metabolic Syndrome, Vol 33, Iss 2, Pp 133-142 (2024)
Background : Triglyceride glucose (TyG) and TyG-body mass index (TyG-BMI) are reliable surrogate indices of insulin resistance and used for risk stratification and outcome prediction in patients with atherosclerotic cardiovascular disease (ASCVD). He
Externí odkaz:
https://doaj.org/article/4826a68bf63e4e1ebf48f883cec324f1
Autor:
Zheng Yin, Zhi-Fan Li, Wen-Jia Zhang, Shuang Zhang, Yong-Gang Sui, Yan-Lu Xu, Hai-Tao Zhang, Xiao-Ning Liu, Hong Qiu, Jing-Lin Zhao, Jian-Jun Li, Ke-Fei Dou, Jie Qian, Yong-Jian Wu, Na-Qiong Wu
Publikováno v:
Heliyon, Vol 9, Iss 11, Pp e22222- (2023)
Background: For the patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI), dual antiplatelet therapy (DAPT) for at least 1 year is recommended in the guidelines to minimize the risk of stent thrombosis. Persi
Externí odkaz:
https://doaj.org/article/e60d00af4d0f417db20d61bcc23279d9
Autor:
Ying-Yi Xie, Liang Zhao, Li-Jian Gao, Rui-Xia Xu, Ying Gao, Ke-Fei Dou, Yuan-Lin Guo, Yong-Ming He
Publikováno v:
Lipids in Health and Disease, Vol 21, Iss 1, Pp 1-10 (2022)
Abstract Background The relationship between remnant cholesterol (RC) and atherosclerotic cardiovascular risk has been given increasing attention in recent years. However, its association with verbal learning and memory performance has not been repor
Externí odkaz:
https://doaj.org/article/b07d6c8043ca4a9cbea070580f033c75
Autor:
Wei Zhang, Jing-Lu Jin, Hui-Wen Zhang, Ya-Xin Zhu, Qian Dong, Jing Sun, Yuan-Lin Guo, Ke-Fei Dou, Rui-Xia Xu, Jian-Jun Li
Publikováno v:
Frontiers in Endocrinology, Vol 14 (2023)
Externí odkaz:
https://doaj.org/article/e4899b3763e642f3a694124d7929822b
Autor:
Hui-Hui Liu, Yuan-Lin Guo, Cheng-Gang Zhu, Na-Qiong Wu, Ying Gao, Rui-Xia Xu, Qian Dong, Jie Qian, Ke-Fei Dou, Jian-Jun Li
Publikováno v:
Journal of Translational Medicine, Vol 20, Iss 1, Pp 1-10 (2022)
Abstract Background Currently, remnant cholesterol (RC), lipoprotein(a) [Lp(a)], and inflammation are considered the principal residual cardiovascular risk (RCVR) factors. This study sought to evaluate the combined impact of RC, Lp(a), and inflammati
Externí odkaz:
https://doaj.org/article/246dafb5cb604f9bbc97bf00a29bffb6
Autor:
Boqun Shi, Hao‐Yu Wang, Jinpeng Liu, Zhongxing Cai, Chenxi Song, Dong Yin, Hongjian Wang, Qiuting Dong, Weihua Song, Ke‐Fei Dou
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 12, Iss 7 (2023)
Background The PRAISE (Prediction of Adverse Events Following an Acute Coronary Syndrome) score is a machine‐learning‐based model for predicting 1‐year all‐cause death, myocardial infarction, and Bleeding Academic Research Consortium (BARC) t
Externí odkaz:
https://doaj.org/article/ccac4c903fad44698dcac0875a5e744b
Autor:
Jia Peng, Ming-Ming Liu, Hui-Hui Liu, Yuan-Lin Guo, Na-Qiong Wu, Qian Dong, Jie Qian, Ke-Fei Dou, Cheng-Gang Zhu, Jian-Jun Li
Publikováno v:
Thrombosis Journal, Vol 19, Iss 1, Pp 1-13 (2021)
Abstract Background Proprotein convertase subtilisin/kexin type 9 (PCSK9) is considered to have multiple roles in the development of atherosclerosis, which is recently reported to participate in the thrombotic process. We aimed to examine the relatio
Externí odkaz:
https://doaj.org/article/bea076379c8d41b38664a1978ae0363b
Autor:
Wei Zhang, Jing-Lu Jin, Hui-Wen Zhang, Ya-Xin Zhu, Qian Dong, Jing Sun, Yuan-Lin Guo, Ke-Fei Dou, Rui-Xia Xu, Jian-Jun Li
Publikováno v:
Frontiers in Endocrinology, Vol 13 (2023)
ObjectiveThe aim of the present study was to examine the value of high-density lipoprotein (HDL) subfractions for predicting cardiovascular events (CVEs) in untreated type 2 diabetes mellitus (T2DM) patients with stable coronary artery disease (SCAD)
Externí odkaz:
https://doaj.org/article/74ae22ae8eb041d9a0c6366f0c5e3b4c
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Low-density lipoprotein cholesterol (LDL-C) has been considered as the primary target for the prevention and treatment of atherosclerotic cardiovascular disease (ASCVD). However, there are still residual cardiovascular risks in some patients even if
Externí odkaz:
https://doaj.org/article/68b95e83b2e44c449d0ec88dcfcf467a